Archive for July 1, 2007

Opportunities for treating chronic hepatitis B and C virus infection using RNA interference

Journal of Viral Hepatitis  Jul 2007 Vol.14  N.7  p.447–459

P. Arbuthnot, V. Longshaw, T. Naidoo and M. S. WeinbergHepatitis B Virus Research Unit, Department of Molecular Medicine and Haematology, University of the Witwatersrand Medical School, Johannesburg, South Africa

Current address: Victoria Longshaw, Chaperone Research Group, Department of Biochemistry, Microbiology and Biotechnology, Rhodes University, Grahamstown, South Africa

abstract
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2006.00818.x
 

July 1, 2007 at 9:51 pm Leave a comment

Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection

Journal of Viral Hepatitis  Jul 2007 Vol.14  N.7  p. 460–467

D. Roulot11Service d’Hépatogastroentérologie, Hôpital Jean Verdier, Bondy, France, V. Bourcier11Service d’Hépatogastroentérologie, Hôpital Jean Verdier, Bondy, France, V. Grando11Service d’Hépatogastroentérologie, Hôpital Jean Verdier, Bondy, France, P. Deny22Laboratoire de Bactériologie-Virologie, Hôpital Avicenne, Bobigny, France, Y. Baazia22Laboratoire de Bactériologie-Virologie, Hôpital Avicenne, Bobigny, France, H. Fontaine33Service d’Hépatologie, Hôpital Necker, Paris, France, F. Bailly44Service d’Hépatologie, Hôpital Hôtel Dieu, Lyon, France, L. Castera1,51Service d’Hépatogastroentérologie, Hôpital Jean Verdier, Bondy, France5Service d’Hépatologie, Hôpital Haut Lévêque, Pessac, France, V. De Ledinghen55Service d’Hépatologie, Hôpital Haut Lévêque, Pessac, France, P. Marcellin66Service d’Hépatologie, Hôpital Beaujon, Clichy, France, R. Poupon77Service d’Hépatologie, Hôpital St Antoine, Paris, France, M. Bourlière88Service d’Hépatologie, Hôpital St Joseph, Marseille, France, J. P. Zarski99Service d’Hépatologie, Hôpital Albert Michallon, Grenoble, France, F. Roudot-Thoraval1010Département de Santé Publique, Hopital Henri Mondor, Créteil, France and The Observational VHC4 Study Group1Service d’Hépatogastroentérologie, Hôpital Jean Verdier, Bondy, France; 2Laboratoire de Bactériologie-Virologie, Hôpital Avicenne, Bobigny, France; 3Service d’Hépatologie, Hôpital Necker, Paris, France; 4Service d’Hépatologie, Hôpital Hôtel Dieu, Lyon, France; 5Service d’Hépatologie, Hôpital Haut Lévêque, Pessac, France; 6Service d’Hépatologie, Hôpital Beaujon, Clichy, France; 7Service d’Hépatologie, Hôpital St Antoine, Paris, France; 8Service d’Hépatologie, Hôpital St Joseph, Marseille, France; 9Service d’Hépatologie, Hôpital Albert Michallon, Grenoble, France; and 10Département de Santé Publique, Hopital Henri Mondor, Créteil, France

Dr Dominique Roulot, Service d’Hépatogastroentérologie, Hôpital Jean Verdier, AP-HP, UPRES-EA 3406, UFR SMBH, Université Paris 13, 93143 Bondy Cedex, France. E-mail: dominique.roulot@avc.aphp.fr

abstract
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2006.00823.x

July 1, 2007 at 9:50 pm Leave a comment

Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4

Journal of Viral Hepatitis  Jul 2007 Vol.14  N.7  p.468–477

A. R. N. Zekri11Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, H. A. Haleem22Tropical Medicine Department, Faculty of Medicine, Cairo University, G. E. -D. Esmat22Tropical Medicine Department, Faculty of Medicine, Cairo University, A. A. Bahnassy33Pathology Department, National Cancer Institute, Cairo University, H. M. A. El-Din11Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, M. M. Hafez11Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, A. F. Sharaby22Tropical Medicine Department, Faculty of Medicine, Cairo University, H. Sharaf44Clinical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt and M. S. E.-D. Zakaria22Tropical Medicine Department, Faculty of Medicine, Cairo University1Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University; 2Tropical Medicine Department, Faculty of Medicine, Cairo University; 3Pathology Department, National Cancer Institute, Cairo University; and 4Clinical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Abdel-Rahman N Zekri, MSc, PhD, Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Fom El-Khalig, Cairo 11796, Egypt. E-mail: ncizakri@starnet.com.eg

abstract
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2006.00832.x

July 1, 2007 at 9:49 pm Leave a comment

EDITORIAL – Visceral leishmaniasis: a threat to immunocompromised patients in non-endemic areas?

Clinical Microbiology and Infection  Aug 2007 Vol.13  N.8 p.751–753

M. Weisser11Division of Infectious Diseases and Hospital Epidemiology, B. Khanlari22Department of Internal Medicine, L. Terracciano33Department of Pathology, C. Arber44Division of Hematology, University Hospital Basel, A. Gratwohl44Division of Hematology, University Hospital Basel, S. Bassetti11Division of Infectious Diseases and Hospital Epidemiology, C. Hatz55Swiss Tropical Institute Basel, Basel, Switzerland, M. Battegay11Division of Infectious Diseases and Hospital Epidemiology and U. Flückiger11Division of Infectious Diseases and Hospital Epidemiology1Division of Infectious Diseases and Hospital Epidemiology, 2Department of Internal Medicine, 3Department of Pathology, 4Division of Hematology, University Hospital Basel and 5Swiss Tropical Institute Basel, Basel, Switzerland

Corresponding author and reprint requests: U. Flückiger, Division of Infectious Diseases, Department of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland

E-mail: uflueckiger@uhbs.ch

abstract
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2007.01755.x

July 1, 2007 at 2:53 pm Leave a comment

ORIGINAL ARTICLE – Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk

Clinical Microbiology and Infection  Aug 2007 Vol.13  N.8 p.763–769

E. Giannitsioti, I. Skiadas, A. Antoniadou, S. Tsiodras, K. Kanavos, H. Triantafyllidi and H. Giamarellou, on behalf of the Hellenic Endocarditis Study Group4th Department of Internal Medicine, Athens University Medical School, Attikon University Hospital, Athens, Greece

Corresponding author and reprint requests: H. Giamarellou, 4th Department of Internal Medicine, University of Athens, University General Hospital Attikon, Rimini 1, 12646 Chaidari, Athens, Greece

E-mail: hgiama@ath.forthnet.gr

abstract
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2007.01746.x

July 1, 2007 at 2:51 pm Leave a comment

ORIGINAL ARTICLE – Characteristics and regional variations of group D streptococcal endocarditis in France

Clinical Microbiology and Infection  Aug 2007 Vol.13  N.8 p.770–776

E. Giannitsioti1,21Service de Maladies Infectieuses et Tropicales, CHU de Besançon, France2University General Hospital Attikon, Athens, Greece, C. Chirouze11Service de Maladies Infectieuses et Tropicales, CHU de Besançon, France, A. Bouvet33Service de Microbiologie, Hôtel-Dieu, Paris, I. Béguinot44Service de Maladies Infectieuses et Tropicales, CHU de Reims, F. Delahaye55Service de Cardiologie, Hospices Civils de Lyon, J.-L. Mainardi66Laboratoire de Bactériologie, Hôpital Georges Pompidou, Paris, M. Celard77Laboratoire de Bactériologie, Hospices Civils de Lyon, L. Mihaila-Amrouche33Service de Microbiologie, Hôtel-Dieu, Paris, V. L. Moing88Service de Maladies Infectieuses et Tropicales, CHU de Montpellier, France and B. Hoen11Service de Maladies Infectieuses et Tropicales, CHU de Besançon, France, on behalf of theAssociation pour l’Etude et la Prévention de l’Endocardite Infectieuse (AEPEI) Study Group1Service de Maladies Infectieuses et Tropicales, CHU de Besançon, France, 2University General Hospital Attikon, Athens, Greece, 3Service de Microbiologie, Hôtel-Dieu, Paris, 4Service de Maladies Infectieuses et Tropicales, CHU de Reims, 5Service de Cardiologie, Hospices Civils de Lyon, 6Laboratoire de Bactériologie, Hôpital Georges Pompidou, Paris, 7Laboratoire de Bactériologie, Hospices Civils de Lyon and 8Service de Maladies Infectieuses et Tropicales, CHU de Montpellier, France

abstract
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2007.01753.x

July 1, 2007 at 2:50 pm Leave a comment

ORIGINAL ARTICLE – Impact of early central venous catheter removal on outcome in patients with candidaemia

Clinical Microbiology and Infection  Aug 2007 Vol.13  N.8 p.788–793

D. Rodriguez11Infectious Diseases Division, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Medicine Department, Barcelona, Spain, B. J. Park22Mycotic Diseases Branch, Division of Foodborne, Bacterial, and Mycotic Diseases, National Center for Zoonotic, Vectorborne, and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA, B. Almirante11Infectious Diseases Division, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Medicine Department, Barcelona, Spain, M. Cuenca-Estrella33Mycology Department, Instituto de Salud Carlos III, Madrid, A. M. Planes44Microbiology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, J. Mensa55Infectious Diseases Division, Hospital Clinic-IDIBAPS, M. Gimenez66Microbiology Department, Hospital Universitari Germans Trias I Pujol, P. Saballs77Infectious Diseases Division, Hospital del Mar, Barcelona, Spain, S. K. Fridkin22Mycotic Diseases Branch, Division of Foodborne, Bacterial, and Mycotic Diseases, National Center for Zoonotic, Vectorborne, and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA, J. L. Rodriguez-Tudela33Mycology Department, Instituto de Salud Carlos III, Madrid and A. Pahissa11Infectious Diseases Division, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Medicine Department, Barcelona, Spain, on behalf of the Barcelona Candidemia Project Study Group*1Infectious Diseases Division, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Medicine Department, Barcelona, Spain, 2Mycotic Diseases Branch, Division of Foodborne, Bacterial, and Mycotic Diseases, National Center for Zoonotic, Vectorborne, and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA, 3Mycology Department, Instituto de Salud Carlos III, Madrid, 4Microbiology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, 5Infectious Diseases Division, Hospital Clinic-IDIBAPS, 6Microbiology Department, Hospital Universitari Germans Trias I Pujol and 7Infectious Diseases Division, Hospital del Mar, Barcelona, Spain

abstract
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2007.01758.x

July 1, 2007 at 2:49 pm Leave a comment

Older Posts


Calendar

July 2007
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Posts by Month

Posts by Category